Ticker Details
Royalty Pharma plc
IPO Date:	June 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$20.69B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.44 | 1.17%
Avg Daily Range (30 D):	$0.49 | 1.05%
Avg Daily Range (90 D):	$0.41 | 0.95%

Institutional Daily Volume
Avg Daily Volume:	2.13M
Avg Daily Volume (30 D):	2.55M
Avg Daily Volume (90 D):	2.78M

Trade Size
Avg Trade Size (Sh.):	91
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	78

Institutional Trades
Total Institutional Trades:	9,569
Avg Institutional Trade:	$4.78M
Avg Institutional Trade (30 D):	$4.38M
Avg Institutional Trade (90 D):	$6.23M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	6

Market Closing Trades
Avg Closing Trade:	$14.52M
Avg Closing Trade (30 D):	$28.92M
Avg Closing Trade (90 D):	$26.1M
Avg Closing Volume:	401.67K

News

Apr 1, 2026 @ 10:00 AM Zymeworks Appoints Kristin Stafford as Chief Finan... Source: Na

Mar 5, 2026 @ 2:00 PM Vera Therapeutics Appoints Christopher Hite to Boa... Source: Not Specified

Mar 2, 2026 @ 12:00 PM Royalty Pharma Appoints Kenneth Sun as Senior Vice... Source: Na

Jan 11, 2026 @ 11:00 PM Teva to Present at the 44th Annual J.P. Morgan Hea... Source: Na

Jan 11, 2026 @ 10:15 PM Royalty Pharma and Teva Enter Agreement to Acceler... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$1.79	$.5	$1.79
Diluted EPS	$1.78	$.5	$1.78
Revenue	$2.38B	$621.99M	$2.38B
Gross Profit
Net Income / Loss	$1.32B	$355.91M	$1.32B
Operating Income / Loss	$1.56B	$388.38M	$1.56B
Cost of Revenue
Net Cash Flow	$-310.33M	$-320.25M	$-310.33M
PE Ratio	27.00

Splits
Oct 15, 2010	1:4